A prospective, open-label, multicenter, single-arm observational registry to describe adherence in relapsing remitting multiple sclerosis patients being prescribed teriflunomide (Aubagio®) in Belgium in routine clinical practice. (AUBADHE) | HMA-EMA Catalogues of real-world data sources and studies